Sponsors: []Modifications: of this Subsection (7)(f).(ii)(iii)  If an individual has not filled a prescription for a Schedule II or III controlledsubstance that is an opiate within the last 90 days, a Schedule II or III controlled substance thatis an opiate may not be filled in a quantity to exceed a seven day supply as directed on the dailydosage rate of the prescription.(iv)(v)(vi)(vii)and.(b)(c)(d)  "Schedule II opioid" means those substances listed in Subsection 58-37-4(2)(b)(i)or (2)(b)(ii).(e)  "Schedule III opioid" means those substances listed in Subsection 58-37-4(2)(c)that are opioids.(2) (a)  Except as provided in Subsection (2)(b), a prescriber shall check the databasefor information about a patient before the first time the prescriber gives a prescription to apatient for a Schedule II opioid or a Schedule III opioid.(b)  A prescriber is not required to check the database under Subsection (2)(a) if:(i)  the prescription for a Schedule II opioid or a Schedule III opioid is for three days orfewer on the daily dosage instructions on the prescription; or(ii)  the prescriber has prior knowledge of the patient's history based on the previousinteractions between the patient and the prescriber, or through the prescriber's access to thepatient's health records.(c)  If a prescriber is repeatedly prescribing a Schedule II opioid or Schedule III opioidto a patient, the prescriber shall periodically review information about the patient in:(i)  the database, or(ii)  other similar records of controlled substances the patient has filled.(d)  ASubsectionsand (2)(c), as determined by the division, demonstrates substantial compliance with thissection.Full text:



1     OPIOID PRESCRIBING REGULATIONS2     2017 GENERAL SESSION3     STATE OF UTAH4     Chief Sponsor:  Raymond P. Ward5     Senate Sponsor:  ____________6      7     LONG TITLE8     General Description:9          This bill amends the Division of Occupational and Professional Licensing Act related to10     the prescribing of certain controlled substances.11     Highlighted Provisions:12          This bill:13                limits the number of days for which an opiate may be prescribed for certain14     individuals;15                removes an outdated provision from the Utah Controlled Substances Act related to16     opiate prescribing; and17                amends provisions of the Controlled Substance Database Act related to provider use18     of the database.19     Money Appropriated in this Bill:20          None21     Other Special Clauses:22          None23     Utah Code Sections Affected:24     AMENDS:25          58-37-6, as last amended by Laws of Utah 2014, Chapter 7826          58-37f-304, as enacted by Laws of Utah 2016, Chapter 27527      28     Be it enacted by the Legislature of the state of Utah:29          Section 1.  Section 58-37-6 is amended to read:30          58-37-6. License to manufacture, produce, distribute, dispense, administer, or31     conduct research -- Issuance by division -- Denial, suspension, or revocation -- Records32     required -- Prescriptions.33          (1) (a)  The division may adopt rules relating to the licensing and control of the34     manufacture, distribution, production, prescription, administration, dispensing, conducting of35     research with, and performing of laboratory analysis upon controlled substances within this36     state.37          (b)  The division may assess reasonable fees to defray the cost of issuing original and38     renewal licenses under this chapter pursuant to Section 63J-1-504.39          (2) (a) (i)  Every person who manufactures, produces, distributes, prescribes, dispenses,40     administers, conducts research with, or performs laboratory analysis upon any controlled41     substance in Schedules I through V within this state, or who proposes to engage in42     manufacturing, producing, distributing, prescribing, dispensing, administering, conducting43     research with, or performing laboratory analysis upon controlled substances included in44     Schedules I through V within this state shall obtain a license issued by the division.45          (ii)  The division shall issue each license under this chapter in accordance with a46     two-year renewal cycle established by rule.  The division may by rule extend or shorten a47     renewal period by as much as one year to stagger the renewal cycles it administers.48          (b)  Persons licensed to manufacture, produce, distribute, prescribe, dispense,49     administer, conduct research with, or perform laboratory analysis upon controlled substances in50     Schedules I through V within this state may possess, manufacture, produce, distribute,51     prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon52     those substances to the extent authorized by their license and in conformity with this chapter.53          (c)  The following persons are not required to obtain a license and may lawfully possess54     controlled substances included in Schedules II through V under this section:55          (i)  an agent or employee, except a sales representative, of any registered manufacturer,56     distributor, or dispenser of any controlled substance, if the agent or employee is acting in the57     usual course of the person's business or employment; however, nothing in this subsection shall58     be interpreted to permit an agent, employee, sales representative, or detail man to maintain an59     inventory of controlled substances separate from the location of the person's employer's60     registered and licensed place of business;61          (ii)  a motor carrier or warehouseman, or an employee of a motor carrier or62     warehouseman, who possesses any controlled substance in the usual course of the person's63     business or employment; and64          (iii)  an ultimate user, or any person who possesses any controlled substance pursuant to65     a lawful order of a practitioner.66          (d)  The division may enact rules waiving the license requirement for certain67     manufacturers, producers, distributors, prescribers, dispensers, administrators, research68     practitioners, or laboratories performing analysis if consistent with the public health and safety.69          (e)  A separate license is required at each principal place of business or professional70     practice where the applicant manufactures, produces, distributes, dispenses, conducts research71     with, or performs laboratory analysis upon controlled substances.72          (f)  The division may enact rules providing for the inspection of a licensee or applicant's73     establishment, and may inspect the establishment according to those rules.74          (3) (a) (i)  Upon proper application, the division shall license a qualified applicant to75     manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon76     controlled substances included in Schedules I through V, unless it determines that issuance of a77     license is inconsistent with the public interest.78          (ii)  The division may not issue a license to any person to prescribe, dispense, or79     administer a Schedule I controlled substance except under Subsection (3)(a)(i).80          (iii)  In determining public interest under this Subsection (3)(a), the division shall81     consider whether or not the applicant has:82          (A)  maintained effective controls against diversion of controlled substances and any83     Schedule I or II substance compounded from any controlled substance into other than84     legitimate medical, scientific, or industrial channels;85          (B)  complied with applicable state and local law;86          (C)  been convicted under federal or state laws relating to the manufacture, distribution,87     or dispensing of substances;88          (D)  past experience in the manufacture of controlled dangerous substances;89          (E)  established effective controls against diversion; and90          (F)  complied with any other factors that the division establishes that promote the public91     health and safety.92          (b)  Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,93     produce, distribute, conduct research with, or perform laboratory analysis upon controlled94     substances in Schedule I other than those specified in the license.95          (c) (i)  Practitioners shall be licensed to administer, dispense, or conduct research with96     substances in Schedules II through V if they are authorized to administer, dispense, or conduct97     research under the laws of this state.98          (ii)  The division need not require a separate license for practitioners engaging in99     research with nonnarcotic controlled substances in Schedules II through V where the licensee is100     already licensed under this chapter in another capacity.101          (iii)  With respect to research involving narcotic substances in Schedules II through V,102     or where the division by rule requires a separate license for research of nonnarcotic substances103     in Schedules II through V, a practitioner shall apply to the division prior to conducting104     research.105          (iv)  Licensing for purposes of bona fide research with controlled substances by a106     practitioner considered qualified may be denied only on a ground specified in Subsection (4),107     or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard108     adequately the practitioner's supply of substances against diversion from medical or scientific109     use.110          (v)  Practitioners registered under federal law to conduct research in Schedule I111     substances may conduct research in Schedule I substances within this state upon furnishing the112     division evidence of federal registration.113          (d)  Compliance by manufacturers, producers, and distributors with the provisions of114     federal law respecting registration, excluding fees, entitles them to be licensed under this115     chapter.116          (e)  The division shall initially license those persons who own or operate an117     establishment engaged in the manufacture, production, distribution, dispensation, or118     administration of controlled substances prior to April 3, 1980, and who are licensed by the119     state.120          (4) (a)  Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed121     on probation, or revoked by the division upon finding that the applicant or licensee has:122          (i)  materially falsified any application filed or required pursuant to this chapter;123          (ii)  been convicted of an offense under this chapter or any law of the United States, or124     any state, relating to any substance defined as a controlled substance;125          (iii)  been convicted of a felony under any other law of the United States or any state126     within five years of the date of the issuance of the license;127          (iv)  had a federal registration or license denied, suspended, or revoked by competent128     federal authority and is no longer authorized to manufacture, distribute, prescribe, or dispense129     controlled substances;130          (v)  had the licensee's license suspended or revoked by competent authority of another131     state for violation of laws or regulations comparable to those of this state relating to the132     manufacture, distribution, or dispensing of controlled substances;133          (vi)  violated any division rule that reflects adversely on the licensee's reliability and134     integrity with respect to controlled substances;135          (vii)  refused inspection of records required to be maintained under this chapter by a136     person authorized to inspect them; or137          (viii)  prescribed, dispensed, administered, or injected an anabolic steroid for the138     purpose of manipulating human hormonal structure so as to:139          (A)  increase muscle mass, strength, or weight without medical necessity and without a140     written prescription by any practitioner in the course of the practitioner's professional practice;141     or142          (B)  improve performance in any form of human exercise, sport, or game.143          (b)  The division may limit revocation or suspension of a license to a particular144     controlled substance with respect to which grounds for revocation or suspension exist.145          (c) (i)  Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to146     this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of147     Occupational and Professional Licensing Act, and conducted in conjunction with the148     appropriate representative committee designated by the director of the department.149          (ii)  Nothing in this Subsection (4)(c) gives the Division of Occupational and150     Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,151     except where the division is designated by law to perform those functions, or, when not152     designated by law, is designated by the executive director of the Department of Commerce to153     conduct the proceedings.154          (d) (i)  The division may suspend any license simultaneously with the institution of155     proceedings under this section if it finds there is an imminent danger to the public health or156     safety.157          (ii)  Suspension shall continue in effect until the conclusion of proceedings, including158     judicial review, unless withdrawn by the division or dissolved by a court of competent159     jurisdiction.160          (e) (i)  If a license is suspended or revoked under this Subsection (4), all controlled161     substances owned or possessed by the licensee may be placed under seal in the discretion of the162     division.163          (ii)  Disposition may not be made of substances under seal until the time for taking an164     appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,165     orders the sale of perishable substances and the proceeds deposited with the court.166          (iii)  If a revocation order becomes final, all controlled substances shall be forfeited.167          (f)  The division shall notify promptly the Drug Enforcement Administration of all168     orders suspending or revoking a license and all forfeitures of controlled substances.169          (g)  If an individual's Drug Enforcement Administration registration is denied, revoked,170     surrendered, or suspended, the division shall immediately suspend the individual's controlled171     substance license, which shall only be reinstated by the division upon reinstatement of the172     federal registration, unless the division has taken further administrative action under173     Subsection (4)(a)(iv), which would be grounds for the continued denial of the controlled174     substance license.175          (5) (a)  Persons licensed under Subsection (2) or (3) shall maintain records and176     inventories in conformance with the record keeping and inventory requirements of federal and177     state law and any additional rules issued by the division.178          (b) (i)  Every physician, dentist, naturopathic physician, veterinarian, practitioner, or179     other person who is authorized to administer or professionally use a controlled substance shall180     keep a record of the drugs received by him and a record of all drugs administered, dispensed, or181     professionally used by him otherwise than by a prescription.182          (ii)  A person using small quantities or solutions or other preparations of those drugs for183     local application has complied with this Subsection (5)(b) if the person keeps a record of the184     quantity, character, and potency of those solutions or preparations purchased or prepared by185     him, and of the dates when purchased or prepared.186          (6)  Controlled substances in Schedules I through V may be distributed only by a187     licensee and pursuant to an order form prepared in compliance with division rules or a lawful188     order under the rules and regulations of the United States.189          (7) (a)  A person may not write or authorize a prescription for a controlled substance190     unless the person is:191          (i)  a practitioner authorized to prescribe drugs and medicine under the laws of this state192     or under the laws of another state having similar standards; and193          (ii)  licensed under this chapter or under the laws of another state having similar194     standards.195          (b)  A person other than a pharmacist licensed under the laws of this state, or the196     pharmacist's licensed intern, as required by Sections 58-17b-303 and 58-17b-304, may not197     dispense a controlled substance.198          (c) (i)  A controlled substance may not be dispensed without the written prescription of199     a practitioner, if the written prescription is required by the federal Controlled Substances Act.200          (ii)  That written prescription shall be made in accordance with Subsection (7)(a) and in201     conformity with Subsection (7)(d).202          (iii)  In emergency situations, as defined by division rule, controlled substances may be203     dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms204     designated by the division and filed by the pharmacy.205          (iv)  Prescriptions reduced to writing by a pharmacist shall be in conformity with206     Subsection (7)(d).207          (d)  Except for emergency situations designated by the division, a person may not issue,208     fill, compound, or dispense a prescription for a controlled substance unless the prescription is209     signed by the prescriber in ink or indelible pencil or is signed with an electronic signature of210     the prescriber as authorized by division rule, and contains the following information:211          (i)  the name, address, and registry number of the prescriber;212          (ii)  the name, address, and age of the person to whom or for whom the prescription is213     issued;214          (iii)  the date of issuance of the prescription; and215          (iv)  the name, quantity, and specific directions for use by the ultimate user of the216     controlled substance.217          (e)  A prescription may not be written, issued, filled, or dispensed for a Schedule I218     controlled substance unless:219          (i)  the person who writes the prescription is licensed under Subsection (2); and220          (ii)  the prescribed controlled substance is to be used in research.221          (f)  Except when administered directly to an ultimate user by a licensed practitioner,222     controlled substances are subject to the [following] restrictions[:] of this Subsection (7)(f).223          (i) [(A)]  A prescription for a Schedule II substance may not be refilled.224          [(B)] (ii)  A Schedule II controlled substance may not be filled in a quantity to exceed a225     one-month's supply, as directed on the daily dosage rate of the prescriptions.226          (iii)  If an individual has not filled a prescription for a Schedule II or III controlled227     substance that is an opiate within the last 90 days, a Schedule II or III controlled substance that228     is an opiate may not be filled in a quantity to exceed a seven day supply as directed on the daily229     dosage rate of the prescription.230          [(ii)] (iv)  A Schedule III or IV controlled substance may be filled only within six231     months of issuance, and may not be refilled more than six months after the date of its original232     issuance or be refilled more than five times after the date of the prescription unless renewed by233     the practitioner.234          [(iii)] (v)  All other controlled substances in Schedule V may be refilled as the235     prescriber's prescription directs, but they may not be refilled one year after the date the236     prescription was issued unless renewed by the practitioner.237          [(iv)] (vi)  Any prescription for a Schedule II substance may not be dispensed if it is not238     presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days239     after the date the prescription was issued, or 30 days after the dispensing date, if that date is240     specified separately from the date of issue.241          [(v)] (vii)  A practitioner may issue more than one prescription at the same time for the242     same Schedule II controlled substance, but only under the following conditions:243          (A)  no more than three prescriptions for the same Schedule II controlled substance may244     be issued at the same time;245          (B)  no one prescription may exceed a 30-day supply; and246          (C)  a second or third prescription shall include the date of issuance and the date for247     dispensing[; and].248          [(D)  unless the practitioner determines there is a valid medical reason to the contrary,249     the date for dispensing a second or third prescription may not be fewer than 30 days from the250     dispensing date of the previous prescription.]251          (g)  An order for a controlled substance in Schedules II through V for use by an252     inpatient or an outpatient of a licensed hospital is exempt from all requirements of this253     Subsection (7) if the order is:254          (i)  issued or made by a prescribing practitioner who holds an unrestricted registration255     with the federal Drug Enforcement Administration, and an active Utah controlled substance256     license in good standing issued by the division under this section, or a medical resident who is257     exempted from licensure under Subsection 58-1-307(1)(c);258          (ii)  authorized by the prescribing practitioner treating the patient and the prescribing259     practitioner designates the quantity ordered;260          (iii)  entered upon the record of the patient, the record is signed by the prescriber261     affirming the prescriber's authorization of the order within 48 hours after filling or262     administering the order, and the patient's record reflects the quantity actually administered; and263          (iv)  filled and dispensed by a pharmacist practicing the pharmacist's profession within264     the physical structure of the hospital, or the order is taken from a supply lawfully maintained by265     the hospital and the amount taken from the supply is administered directly to the patient266     authorized to receive it.267          (h)  A practitioner licensed under this chapter may not prescribe, administer, or268     dispense a controlled substance to a child, without first obtaining the consent required in269     Section 78B-3-406 of a parent, guardian, or person standing in loco parentis of the child except270     in cases of an emergency.  For purposes of this Subsection (7)(h), "child" has the same271     meaning as defined in Section 78A-6-105, and "emergency" means any physical condition272     requiring the administration of a controlled substance for immediate relief of pain or suffering.273          (i)  A practitioner licensed under this chapter may not prescribe or administer dosages274     of a controlled substance in excess of medically recognized quantities necessary to treat the275     ailment, malady, or condition of the ultimate user.276          (j)  A practitioner licensed under this chapter may not prescribe, administer, or dispense277     any controlled substance to another person knowing that the other person is using a false name,278     address, or other personal information for the purpose of securing the controlled substance.279          (k)  A person who is licensed under this chapter to manufacture, distribute, or dispense280     a controlled substance may not manufacture, distribute, or dispense a controlled substance to281     another licensee or any other authorized person not authorized by this license.282          (l)  A person licensed under this chapter may not omit, remove, alter, or obliterate a283     symbol required by this chapter or by a rule issued under this chapter.284          (m)  A person licensed under this chapter may not refuse or fail to make, keep, or285     furnish any record notification, order form, statement, invoice, or information required under286     this chapter.287          (n)  A person licensed under this chapter may not refuse entry into any premises for288     inspection as authorized by this chapter.289          (o)  A person licensed under this chapter may not furnish false or fraudulent material290     information in any application, report, or other document required to be kept by this chapter or291     willfully make any false statement in any prescription, order, report, or record required by this292     chapter.293          (8) (a) (i)  Any person licensed under this chapter who is found by the division to have294     violated any of the provisions of Subsections (7)(k) through (o) or Subsection (10) is subject to295     a penalty not to exceed $5,000.  The division shall determine the procedure for adjudication of296     any violations in accordance with Sections 58-1-106 and 58-1-108.297          (ii)  The division shall deposit all penalties collected under Subsection (8)(a)(i) in the298     General Fund as a dedicated credit to be used by the division under Subsection 58-37f-502(1).299          (b)  Any person who knowingly and intentionally violates Subsections (7)(h) through (j)300     or Subsection (10) is:301          (i)  upon first conviction, guilty of a class B misdemeanor;302          (ii)  upon second conviction, guilty of a class A misdemeanor; and303          (iii)  on third or subsequent conviction, guilty of a third degree felony.304          (c)  Any person who knowingly and intentionally violates Subsections (7)(k) through305     (o) shall upon conviction be guilty of a third degree felony.306          (9)  Any information communicated to any licensed practitioner in an attempt to307     unlawfully procure, or to procure the administration of, a controlled substance is not considered308     to be a privileged communication.309          (10)  A person holding a valid license under this chapter who is engaged in medical310     research may produce, possess, administer, prescribe, or dispense a controlled substance for311     research purposes as licensed under Subsection (2) but may not otherwise prescribe or dispense312     a controlled substance listed in Section 58-37-4.2.313          Section 2.  Section 58-37f-304 is amended to read:314          58-37f-304. Database utilization.315          (1)  As used in this section:316          (a)  "Dispenser" means a licensed pharmacist, as described in Section 58-17b-303, or317     the pharmacist's licensed intern, as described in Section 58-17b-304, who is also licensed to318     dispense a controlled substance under Title 58, Chapter 37, Utah Controlled Substances Act.319          [(b)  "Opioid" means those substances listed in Subsection 58-37-4(2)(b)(i) or320     (2)(b)(ii).]321          [(c)] (b)  "Outpatient" means a setting in which an individual visits a licensed322     healthcare facility or a healthcare provider's office for a diagnosis or treatment but is not323     admitted to a licensed healthcare facility for an overnight stay.324          [(d)] (c)  "Prescriber" means an individual authorized to prescribe a controlled325     substance under Title 58, Chapter 37, Utah Controlled Substances Act.326          [(2)  To address the serious public health concern of life-altering and life-threatening327     opioid abuse and overdose, and to achieve the purposes of this chapter and as described in328     Section 58-37f-201, which includes identifying and reducing the prescribing and dispensing of329     opioids in an unprofessional or unlawful manner or in quantities or frequencies inconsistent330     with generally recognized standards of dosage for an opioid, through utilization of the carefully331     developed and highly respected database:]332          [(a)  a prescriber or dispenser of an opioid for individual outpatient usage shall access333     and review the database as necessary in the prescriber's or dispenser's professional judgment334     and to achieve the purpose of this chapter as described in Section 58-37f-201; (b) a]335          (d)  "Schedule II opioid" means those substances listed in Subsection 58-37-4(2)(b)(i)336     or (2)(b)(ii).337          (e)  "Schedule III opioid" means those substances listed in Subsection 58-37-4(2)(c)338     that are opioids.339          (2) (a)  Except as provided in Subsection (2)(b), a prescriber shall check the database340     for information about a patient before the first time the prescriber gives a prescription to a341     patient for a Schedule II opioid or a Schedule III opioid.342          (b)  A prescriber is not required to check the database under Subsection (2)(a) if:343          (i)  the prescription for a Schedule II opioid or a Schedule III opioid is for three days or344     fewer on the daily dosage instructions on the prescription; or345          (ii)  the prescriber has prior knowledge of the patient's history based on the previous346     interactions between the patient and the prescriber, or through the prescriber's access to the347     patient's health records.348          (c)  If a prescriber is repeatedly prescribing a Schedule II opioid or Schedule III opioid349     to a patient, the prescriber shall periodically review information about the patient in:350          (i)  the database, or351          (ii)  other similar records of controlled substances the patient has filled.352          (d)  A prescriber may assign the access and review required under [Subsection]353     Subsections (2)(a) and (2)(c) to an employee, in accordance with Subsections 58-37f-301(2)(g)354     and (h).355          (3)  The division shall, in collaboration with the licensing boards for prescribers and356     dispensers:357          (a)  develop a system that gathers and reports to prescribers and dispensers the progress358     and results of the prescriber's and dispenser's individual access and review of the database, as359     provided in this section; and360          (b)  reduce or waive the division's continuing education requirements regarding opioid361     prescriptions, described in Section 58-37-6.5, including the online tutorial and test relating to362     the database, for prescribers and dispensers whose individual utilization of the database363     [contribute to the life-saving and public safety purposes of this section and as described in364     Subsection (2).], as determined by the division, demonstrates substantial compliance with this365     section.366          (4)  If the dispenser's access and review of the database suggest that the individual367     seeking an opioid may be obtaining opioids in quantities or frequencies inconsistent with368     generally recognized standards as provided in this section and Section 58-37f-201, the369     dispenser shall reasonably attempt to contact the prescriber to obtain the prescriber's informed,370     current, and professional decision regarding whether the prescribed opioid is medically371     justified, notwithstanding the results of the database search.Legislative Review NoteOffice of Legislative Research and General Counsel

